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Venous thromboembolic disease (VTE), the term given when
deep venous thrombosis (DVT) and pulmonary embolism (PE)
present together, is a national health hazard. VTE accounts for
an estimated 900,000 cases yearly, resulting in approximately
300,000 deaths annually. Thrombus in the vein leads to vein wall
fibrotic injury and sets the stage for post-thrombotic syndrome,
one of the major complications of DVT, or chronic thrombotic
pulmonary hypertension, one of the major complications of PE.
Although many thrombotic events are spontaneous in the
absence of malignancy, patients with tumors have a high incidence
and risk of VTE in the early months after diagnosis, and these risks
are further augmented with metastatic disease. VTE is a leading
cause of death in cancer patients—the prothrombotic state of
malignancy is complex andmultifactorial. In the current article, De
Martino et al establish that different malignancies have different
thrombotic potential by using administrative data from the Amer-
ican College of Surgeons-National Surgical Quality Improvement
Program and an analysis of 43,000 cancer patients.
Although this fact has been known, the unique feature of the
current article is defined by the statement in the discussion that
“variation in VTE risk among patients undergoing surgical resec-
tion may differ not only by cancer, but also by the associated
resection magnitude.” Patients who underwent breast surgery, gastrectomy, lung resection, prostatectomy, colectomy, pancreatec-
omy, esophagectomy, hysterectomy, hepatectomy, cystectomy, and ne-
hrectomywere evaluated. Compared with breast resection, the authors
ound prostatectomy, colectomy, esophagectomy, hysterectomy, and
epatectomy had a greater than twofold odds ratio for DVT. Every
peration evaluated, except esophagectomy, had increased odds for PE
with hysterectomy and cystectomy at very high risk, 5.5-fold and 6.4-
old odds ratio), and prostatectomy, esophagectomy, hysterectomy, and
epatectomy were associated with the development of VTE. One inter-
stingfindingwas thedifference among thoseprocedures associatedwith
VT and not PE, and vice versa. Multivariate analysis also identified
actors associatedwithDVT,PE,andVTE,withprolonged lengthof stay
nd wound infection associated with all three conditions.
As with any study based on administrative data, some of the
etails necessary for a full analysis are not available, and certain
actors, such as prophylaxis use, are not available from the National
urgical Quality Improvement Program database. Nonetheless,
his important study sets the stage for the development of further
prospective cohort studies . . . to validate risk of VTE in patients
ndergoing various cancer surgeries” and also suggests that studies
o determine best prophylaxis use are indicated, potentially with
ifferent cancer resections requiring different prophylaxis strate-
ies.
